[Skip To Content]
[Website of the National Cancer Institute's Technology Transfer Center.  Partnering with Industry for Improved Public Health.]
  • Home
  • Collaborative Opportunities
  • Standard Forms and Agreements
  • Technology Transfer Training
  • Resources
  • Intellectual Property

Carbon Nanotube Transistor -Based Microarray Binding Sensors

Background:
The National Cancer Institute's Oncogenomics Section is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize electronic detection of nucleic acid and protein levels.

Description of Technology:
This technology consists of:
a) an apparatus containing microarray binding sensors having biological probe materials and carbon nanotube (CNT) transistors; and
b) various methods of using the highly sensitive CNT transistors for the electronic detection of nucleic acid hybridization for performing microarray gene expression experiments.

Additionally, these methods can be used to detect DNA-DNA, DNA-RNA, Peptide Nucleic Acid (PNA) -DNA, PNA-RNA, DNA-protein or PNA-protein binding. By analogy to the microarray concept, each transistor is associated with a distinct probe oligonucleotide and is operated as a field effect transistor (FET). The transconductance between the source and drain electrodes is measured both before and after a hybridization event.

In addition to increased sensitivity and ease of use, this technology eliminates the need for chemical labeling and enzymatic manipulation. This design is distinct from other CNT-based biomolecular sensing schemes in that the CNT transistors function only as charge sensors and are completely isolated from chemical reactions concomitant with probe immobilization and target capture. In contrast, current methods rely on enzymatic amplification of nucleic acids, fluorescent labeled targets, hybridization, amplification of signal and detection by optical scanners, which are time consuming and have limited sensitivity.

The apparatus and methods can be used for numerous applications, including high-throughput monitoring of genome-wide DNA and mRNA copy number changes; sequencing of DNA; and identification of miRNA levels in cancer and of targets of transcription factors. Furthermore, given the intensity of effort in linking gene expression with diseases, it is only a matter of time before diagnosis and prognosis of certain ailments can be performed on the basis of gene expression. Presently, most such analyses require costly apparatus and labor-intensive laboratory procedures.

Value Proposition Solution:
  • Microarray binding sensors using CNT transistors which detect nucleic acid and protein levels with increased sensitivity and ease of use
  • Elimination of chemical labeling and enzymatic manipulation
  • Ability to perform numerous laboratory procedures, including sequencing of DNA and identification of miRNA levels in cancer, less expensively and more efficiently
R&D Status: Prototype development

Further R&D Needed:
  • Microfluidics
  • Developing hand held device for working the field
  • Signal processing
  • Pattern recognition algorithm
  • Detection of protein levels using antibodies or Aptamers
  • Mutational detection
IP Status:
  • U.S. Patent Application No. 60/743,524 filed 17 Mar 2006
  • U.S. Patent Application No. 11/723,369 filed 19 Mar 2007

Contact Information:
John D. Hewes, Ph.D., NCI Technology Transfer Center
Phone: 301-435-3121
E-mail: Hewesj@mail.nih.gov

Reference:  #662 PM

Posted 05/08/2008

This opportunity is also listed under the following categories:


E-MAIL SERVICE

TTC maintains an e-mail service to notify you of new Collaborative Opportunities. If you would like to receive these emails, please sign up below. If you'd like to unsubscribe you can use this form as well.

Page Last Updated: 12-17-2008